ask="N/A"
ask_size="N/A"
average_daily_volume="1061120"
bid="2.49"
bid_size="6000"
book_value="-0.03"
change="+0.02"
change_from_200_day_moving_average="0.94"
change_from_50_day_moving_average="0.58"
change_from_52_week_high="-1.30"
change_From_52_week_low="1.59"
change_in_percent="+0.75%"
close="2.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.51"
ebitda="-13.34M"
eps_estimate_current_year="-1.23"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.44"
ex_dividend_date="N/A"
float_shares="4867000"
high="2.85"
high_52_weeks="4.00"
last_trade_date="3/13/2017"
last_trade_price="2.70"
last_trade_size="695"
last_trade_time="4:00pm"
low="2.60"
low_52_weeks="1.11"
market_capitalization="27.63M"
moving_average_200_day="1.76"
moving_average_50_day="2.12"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="2.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+53.84%"
percent_change_from_50_day_moving_average="+27.30%"
percent_change_from_52_week_high="-32.50%"
percent_change_from_52_week_low="+143.24%"
previous_close="2.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="2.84"
price_per_book="N/A"
price_per_sales="40.98"
revenue="669259.00"
shares_outstanding="10234000"
short_ratio="1.02"
stock_exchange="NCM"
symbol="EYEG"
volume="282632"
weeks_range_52="1.11 - 4.00"
